Why the study?
Does ECMO improve outcomes in pregnant patients with severe ARDS secondary to H1N1 influenza?
Does ECMO improve outcomes in pregnant patients with severe ARDS secondary to H1N1 influenza?
ECMO can be safely used in pregnant patients with severe ARDS, yielding good maternal and fetal outcomes.
Extracorporeal membrane oxygenation (ECMO) is a technique that provides support to selected patients with severe respiratory failure. During the 2009 H1N1 influenza infection outbreak, ECMO was used with a good impact on survival for pregnant women, who are at higher risk of H1N1 influenza infection. However, there is little information about the survival of fetus post-ECMO therapy in the literature. We present a case report of a pregnant patient with severe adult respiratory distress syndrome secondary to 2009 H1N1 influenza treated with ECMO. The outcome was good both for the mother and her fetus. At 1-year follow-up, her child had no neurological or clinical abnormalities. We conclude that ECMO can be used safely during pregnancy with a good neurological and clinical outcome for the fetus.
No takes yet. Share an insight, caveat, or question.
Courouble et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: